173 related articles for article (PubMed ID: 36221263)
1. Targeted metabolomic profiles of serum amino acids and acylcarnitines related to gastric cancer.
Li D; Lu Y; Zhao F; Yan L; Yang X; Wei L; Yang X; Yuan X; Yang K
PeerJ; 2022; 10():e14115. PubMed ID: 36221263
[TBL] [Abstract][Full Text] [Related]
2. Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients.
Corona G; Cannizzaro R; Miolo G; Caggiari L; De Zorzi M; Repetto O; Steffan A; De Re V
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29518896
[TBL] [Abstract][Full Text] [Related]
3. Serum OPN expression for identification of gastric cancer and atrophic gastritis and its influencing factors.
Chen T; Sun L; He C; Gong Y; Xu Q; Yuan Y
PLoS One; 2014; 9(12):e114005. PubMed ID: 25479069
[TBL] [Abstract][Full Text] [Related]
4. Significance of Serum Pepsinogens as a Biomarker for Gastric Cancer and Atrophic Gastritis Screening: A Systematic Review and Meta-Analysis.
Huang YK; Yu JC; Kang WM; Ma ZQ; Ye X; Tian SB; Yan C
PLoS One; 2015; 10(11):e0142080. PubMed ID: 26556485
[TBL] [Abstract][Full Text] [Related]
5. Atrophic gastritis and gastric cancer tissue miRNome analysis reveals hsa-miR-129-1 and hsa-miR-196a as potential early diagnostic biomarkers.
Varkalaite G; Vaitkeviciute E; Inciuraite R; Salteniene V; Juzenas S; Petkevicius V; Gudaityte R; Mickevicius A; Link A; Kupcinskas L; Leja M; Kupcinskas J; Skieceviciene J
World J Gastroenterol; 2022 Feb; 28(6):653-663. PubMed ID: 35317427
[TBL] [Abstract][Full Text] [Related]
6. Discriminating gastric cancer and gastric ulcer using human plasma amino acid metabolic profile.
Jing F; Hu X; Cao Y; Xu M; Wang Y; Jing Y; Hu X; Gao Y; Zhu Z
IUBMB Life; 2018 Jun; 70(6):553-562. PubMed ID: 29626382
[TBL] [Abstract][Full Text] [Related]
7. LncRNAs adjacent to pepsinogen C in gastric diseases and diagnostic efficiencies of joint detection in gastric diseases.
Liu WJ; Lv Z; Liu JW; Xu Q; Ding HX; Yuan Y
Future Oncol; 2020 Apr; 16(11):655-663. PubMed ID: 32242461
[No Abstract] [Full Text] [Related]
8. Metabolomic phenotype of gastric cancer and precancerous stages based on gas chromatography time-of-flight mass spectrometry.
Yu L; Aa J; Xu J; Sun M; Qian S; Cheng L; Yang S; Shi R
J Gastroenterol Hepatol; 2011 Aug; 26(8):1290-7. PubMed ID: 21443661
[TBL] [Abstract][Full Text] [Related]
9. Promoter polymorphisms in trefoil factor 2 and trefoil factor 3 genes and susceptibility to gastric cancer and atrophic gastritis among Chinese population.
Xu Q; Chen MY; He CY; Sun LP; Yuan Y
Gene; 2013 Oct; 529(1):104-12. PubMed ID: 23933418
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of H. pylori Infection and Atrophic Gastritis in a Population-based Screening with Serum Biomarker Panel (GastroPanel®) in St. Petersburg.
Roman LD; Lukyanchuk R; Sablin OA; Araslanova EI; Eklund C; Hendolin P; Paloheimo L; Syrjänen K
Anticancer Res; 2016 Aug; 36(8):4129-38. PubMed ID: 27466521
[TBL] [Abstract][Full Text] [Related]
11. Serum miR-101-3p combined with pepsinogen contributes to the early diagnosis of gastric cancer.
Zeng W; Zhang S; Yang L; Wei W; Gao J; Guo N; Wu F
BMC Med Genet; 2020 Feb; 21(1):28. PubMed ID: 32041551
[TBL] [Abstract][Full Text] [Related]
12. Measurement of free carnitine and acylcarnitines in plasma by HILIC-ESI-MS/MS without derivatization.
Peng M; Liu L; Jiang M; Liang C; Zhao X; Cai Y; Sheng H; Ou Z; Luo H
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():12-8. PubMed ID: 23816563
[TBL] [Abstract][Full Text] [Related]
13. [Screening of serum oxysterol biomarkers for colon cancer by liquid chromatography-tandem mass spectrometry].
Ma Z; Li Z; Wang H; Wang R; Han X
Se Pu; 2022 Jun; 40(6):541-546. PubMed ID: 35616199
[TBL] [Abstract][Full Text] [Related]
14. The Serum Pepsinogen Test as a Predictor of Kazakh Gastric Cancer.
Juan Cai W; Yin L; Kang Q; Chen Zeng Z; Liang Wang S; Cheng J
Sci Rep; 2017 Mar; 7():43536. PubMed ID: 28251999
[TBL] [Abstract][Full Text] [Related]
15. Regulation of apoptosis is impaired in atrophic gastritis associated with gastric cancer.
Rosania R; Varbanova M; Wex T; Langner C; Bornschein J; Giorgio F; Ierardi E; Malfertheiner P
BMC Gastroenterol; 2017 Jun; 17(1):84. PubMed ID: 28662697
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic values of serum levels of pepsinogens and gastrin-17 for screening gastritis and gastric cancer in a high risk area in northern Iran.
Nejadi-Kelarijani F; Roshandel G; Semnani S; Ahmadi A; Faghani B; Besharat S; Akhavan-Tabib A; Amiriani T
Asian Pac J Cancer Prev; 2014; 15(17):7433-6. PubMed ID: 25227854
[TBL] [Abstract][Full Text] [Related]
17. A quantitative multimodal metabolomic assay for colorectal cancer.
Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
[TBL] [Abstract][Full Text] [Related]
18. A panel of stomach-specific biomarkers (GastroPanel®) for the diagnosis of atrophic gastritis: A prospective, multicenter study in a low gastric cancer incidence area.
Chapelle N; Petryszyn P; Blin J; Leroy M; Le Berre-Scoul C; Jirka I; Neunlist M; Moussata D; Lamarque D; Olivier R; Tougeron D; Mosnier JF; Matysiak-Budnik T
Helicobacter; 2020 Oct; 25(5):e12727. PubMed ID: 32700438
[TBL] [Abstract][Full Text] [Related]
19. Serum Metabolic Profiling Analysis of Chronic Gastritis and Gastric Cancer by Untargeted Metabolomics.
Yu L; Lai Q; Feng Q; Li Y; Feng J; Xu B
Front Oncol; 2021; 11():636917. PubMed ID: 33777793
[TBL] [Abstract][Full Text] [Related]
20. The correlation of serum sirt6 with clinical outcome and prognosis in patients with gastric cancer.
Li D; Cao C
Medicine (Baltimore); 2022 Nov; 101(47):e31568. PubMed ID: 36451443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
